Skip to content
SYNTHREXBiotech

Cytoprotective Research Peptides

Cytoprotection describes a cell’s capacity to withstand insult, and the peptides grouped here were characterised in that literature rather than in any single tissue. BPC-157 came out of a question asked at the University of Zagreb in 1975 — if the stomach lining survives its own acid, is there something protective in gastric juice? — and the synthetic pentadecapeptide was formally described in 1993. TB-500 arrived by a different route: thymosin beta-4 was sequenced from bovine thymus in 1981 as a presumed thymic hormone, then reclassified once it was identified as a major G-actin sequestering protein. That reclassification, from immune factor to regulator of the cytoskeleton, is why it appears in this literature at all. What the class shares is a mechanism described at the level of the cell — angiogenic signalling, nitric oxide interaction, actin dynamics — studied almost entirely in rodent and cell-culture models.

5 compounds · For research use only. Not for human consumption.

5 of 5 products

BPC-157 research vial — for laboratory research use only
Cytoprotective

BPC-157

COA published

A synthetic pentadecapeptide studied in in-vitro models of tissue-repair signalling and cellular migration.

From$54.00Select size
TB-500 research vial — for laboratory research use only
Cytoprotective

TB-500

COA published

A thymosin beta-4 fragment investigated in research on cellular migration and angiogenesis pathways.

$50.00View
BPC-157 + TB-500 Blend research vial — for laboratory research use only
Cytoprotective

BPC-157 + TB-500 Blend

COA published

A combined preparation of BPC-157 and TB-500 used in comparative tissue-repair research models.

From$90.00Select size
GLOW Blend research vial — for laboratory research use only
Cytoprotective

GLOW Blend

A combined BPC-157, GHK-Cu and TB-500 preparation studied in dermal and repair research contexts.

From$89.00Select size
KLOW Blend research vial — for laboratory research use only
Cytoprotective

KLOW Blend

COA published

A combined GHK-Cu, KPV, BPC-157 and TB-500 preparation used in multi-pathway research models.

From$92.00Select size

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.